Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,626 INR | +1.74% | +3.57% | +1.88% |
May. 14 | Nomura Upgrades Dr. Lal Pathlabs to Buy From Neutral, Adjusts Price Target to INR2,713 From INR2,505 | MT |
May. 13 | Dr. Lal Pathlabs' Fiscal Q4 Consolidated Net Profit Rises; Share Up 6% | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.88% | 2.63B | |
-23.32% | 7.86B | |
-8.06% | 2.5B | |
-41.95% | 2.33B | |
-11.99% | 1.82B | |
-21.18% | 1.51B | |
+17.44% | 1.22B | |
-43.89% | 1.14B | |
+14.78% | 957M | |
-9.93% | 948M |
- Stock Market
- Equities
- LALPATHLAB Stock
- News Dr. Lal PathLabs Limited
- Dr Lal Pathlabs' Consolidated Profit Jumps in Fiscal Q1; Revenue Meets Estimates